Cargando…

Clinical significance of tumor-infiltrating lymphocytes investigated using routine H&E slides in small cell lung cancer

BACKGROUND: Tumor-infiltrating lymphocytes (TILs), investigated using routine hematoxylin and eosin (H&E)-stained section slides (H&E-sTILs), provide a robust prognostic biomarker in various types of solid cancer. The purpose of the present study was to investigate the prognostic significanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Guangrun, Zheng, Jifang, Chen, Zhiwei, Hu, Dan, Li, Suyu, Zhuang, Wu, He, Zhiyong, Lin, Gen, Wu, Biao, Zhang, Wei, Fang, Weimin, Zheng, Fei, Wang, Jiezhong, Chen, Gang, Chen, Mingqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290232/
https://www.ncbi.nlm.nih.gov/pubmed/35850908
http://dx.doi.org/10.1186/s13014-022-02098-z
_version_ 1784748852653326336
author Zhou, Guangrun
Zheng, Jifang
Chen, Zhiwei
Hu, Dan
Li, Suyu
Zhuang, Wu
He, Zhiyong
Lin, Gen
Wu, Biao
Zhang, Wei
Fang, Weimin
Zheng, Fei
Wang, Jiezhong
Chen, Gang
Chen, Mingqiu
author_facet Zhou, Guangrun
Zheng, Jifang
Chen, Zhiwei
Hu, Dan
Li, Suyu
Zhuang, Wu
He, Zhiyong
Lin, Gen
Wu, Biao
Zhang, Wei
Fang, Weimin
Zheng, Fei
Wang, Jiezhong
Chen, Gang
Chen, Mingqiu
author_sort Zhou, Guangrun
collection PubMed
description BACKGROUND: Tumor-infiltrating lymphocytes (TILs), investigated using routine hematoxylin and eosin (H&E)-stained section slides (H&E-sTILs), provide a robust prognostic biomarker in various types of solid cancer. The purpose of the present study was to investigate the prognostic significance of H&E-sTILs in patients with small cell lung cancer (SCLC). METHODS: The clinical data of patients with SCLC who had been treated in our cancer center between January 2013 and October 2019 were collected and retrospectively reviewed. The H&E-sTILs were re-assessed by two experienced pathologists independently. H&E-sTILs that affected the overall survival (OS), progression free survival (PFS) and brain-metastasis free survival (BMFS) rates were explored using the Kaplan–Meier method, and the log-rank test was used to assess the differences. Multivariate analysis was subsequently performed using the Cox proportion hazards model. RESULTS: A total of 159 patients with SCLC who fulfilled the inclusion criteria were enrolled in the current study. The OS rates at 1, 2 and 3 years were 59.8, 28.6 and 19.8%, respectively, for the whole group. The 3-year OS, PFS and BMFS rates for the H&E-sTILs(+) and H&E-sTILs(−) groups were 25.1% cf. 5.1% (P = 0.030), 14.0% cf. 4.0% (P = 0.013), and 66.0% cf. 11.4% (P = 0.023), respectively. Multivariate analyses subsequently revealed that H&E-sTILs, clinical M stage, the cycles of chemotherapy and short-term response to thoracic radiotherapy were independent factors affecting OS, whereas H&E-sTILs, clinical N stage, clinical M stage and short-term response to chemotherapy were factors affecting PFS. The H&E-sTILs affected OS, PFS and BMFS simultaneously. CONCLUSIONS: The results of this retrospective study have shown that H&E-sTILs may be considered as a prognostic biomarker affecting the short-term response to treatment, and they are the one and only risk factor for BMFS. However, due to the limitations of the nature of the retrospective design and shortcomings in visually assessing the TILs based on the H&E-stained slides, further prospective studies are required to confirm these conclusions.
format Online
Article
Text
id pubmed-9290232
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92902322022-07-19 Clinical significance of tumor-infiltrating lymphocytes investigated using routine H&E slides in small cell lung cancer Zhou, Guangrun Zheng, Jifang Chen, Zhiwei Hu, Dan Li, Suyu Zhuang, Wu He, Zhiyong Lin, Gen Wu, Biao Zhang, Wei Fang, Weimin Zheng, Fei Wang, Jiezhong Chen, Gang Chen, Mingqiu Radiat Oncol Review BACKGROUND: Tumor-infiltrating lymphocytes (TILs), investigated using routine hematoxylin and eosin (H&E)-stained section slides (H&E-sTILs), provide a robust prognostic biomarker in various types of solid cancer. The purpose of the present study was to investigate the prognostic significance of H&E-sTILs in patients with small cell lung cancer (SCLC). METHODS: The clinical data of patients with SCLC who had been treated in our cancer center between January 2013 and October 2019 were collected and retrospectively reviewed. The H&E-sTILs were re-assessed by two experienced pathologists independently. H&E-sTILs that affected the overall survival (OS), progression free survival (PFS) and brain-metastasis free survival (BMFS) rates were explored using the Kaplan–Meier method, and the log-rank test was used to assess the differences. Multivariate analysis was subsequently performed using the Cox proportion hazards model. RESULTS: A total of 159 patients with SCLC who fulfilled the inclusion criteria were enrolled in the current study. The OS rates at 1, 2 and 3 years were 59.8, 28.6 and 19.8%, respectively, for the whole group. The 3-year OS, PFS and BMFS rates for the H&E-sTILs(+) and H&E-sTILs(−) groups were 25.1% cf. 5.1% (P = 0.030), 14.0% cf. 4.0% (P = 0.013), and 66.0% cf. 11.4% (P = 0.023), respectively. Multivariate analyses subsequently revealed that H&E-sTILs, clinical M stage, the cycles of chemotherapy and short-term response to thoracic radiotherapy were independent factors affecting OS, whereas H&E-sTILs, clinical N stage, clinical M stage and short-term response to chemotherapy were factors affecting PFS. The H&E-sTILs affected OS, PFS and BMFS simultaneously. CONCLUSIONS: The results of this retrospective study have shown that H&E-sTILs may be considered as a prognostic biomarker affecting the short-term response to treatment, and they are the one and only risk factor for BMFS. However, due to the limitations of the nature of the retrospective design and shortcomings in visually assessing the TILs based on the H&E-stained slides, further prospective studies are required to confirm these conclusions. BioMed Central 2022-07-18 /pmc/articles/PMC9290232/ /pubmed/35850908 http://dx.doi.org/10.1186/s13014-022-02098-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Zhou, Guangrun
Zheng, Jifang
Chen, Zhiwei
Hu, Dan
Li, Suyu
Zhuang, Wu
He, Zhiyong
Lin, Gen
Wu, Biao
Zhang, Wei
Fang, Weimin
Zheng, Fei
Wang, Jiezhong
Chen, Gang
Chen, Mingqiu
Clinical significance of tumor-infiltrating lymphocytes investigated using routine H&E slides in small cell lung cancer
title Clinical significance of tumor-infiltrating lymphocytes investigated using routine H&E slides in small cell lung cancer
title_full Clinical significance of tumor-infiltrating lymphocytes investigated using routine H&E slides in small cell lung cancer
title_fullStr Clinical significance of tumor-infiltrating lymphocytes investigated using routine H&E slides in small cell lung cancer
title_full_unstemmed Clinical significance of tumor-infiltrating lymphocytes investigated using routine H&E slides in small cell lung cancer
title_short Clinical significance of tumor-infiltrating lymphocytes investigated using routine H&E slides in small cell lung cancer
title_sort clinical significance of tumor-infiltrating lymphocytes investigated using routine h&e slides in small cell lung cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290232/
https://www.ncbi.nlm.nih.gov/pubmed/35850908
http://dx.doi.org/10.1186/s13014-022-02098-z
work_keys_str_mv AT zhouguangrun clinicalsignificanceoftumorinfiltratinglymphocytesinvestigatedusingroutineheslidesinsmallcelllungcancer
AT zhengjifang clinicalsignificanceoftumorinfiltratinglymphocytesinvestigatedusingroutineheslidesinsmallcelllungcancer
AT chenzhiwei clinicalsignificanceoftumorinfiltratinglymphocytesinvestigatedusingroutineheslidesinsmallcelllungcancer
AT hudan clinicalsignificanceoftumorinfiltratinglymphocytesinvestigatedusingroutineheslidesinsmallcelllungcancer
AT lisuyu clinicalsignificanceoftumorinfiltratinglymphocytesinvestigatedusingroutineheslidesinsmallcelllungcancer
AT zhuangwu clinicalsignificanceoftumorinfiltratinglymphocytesinvestigatedusingroutineheslidesinsmallcelllungcancer
AT hezhiyong clinicalsignificanceoftumorinfiltratinglymphocytesinvestigatedusingroutineheslidesinsmallcelllungcancer
AT lingen clinicalsignificanceoftumorinfiltratinglymphocytesinvestigatedusingroutineheslidesinsmallcelllungcancer
AT wubiao clinicalsignificanceoftumorinfiltratinglymphocytesinvestigatedusingroutineheslidesinsmallcelllungcancer
AT zhangwei clinicalsignificanceoftumorinfiltratinglymphocytesinvestigatedusingroutineheslidesinsmallcelllungcancer
AT fangweimin clinicalsignificanceoftumorinfiltratinglymphocytesinvestigatedusingroutineheslidesinsmallcelllungcancer
AT zhengfei clinicalsignificanceoftumorinfiltratinglymphocytesinvestigatedusingroutineheslidesinsmallcelllungcancer
AT wangjiezhong clinicalsignificanceoftumorinfiltratinglymphocytesinvestigatedusingroutineheslidesinsmallcelllungcancer
AT chengang clinicalsignificanceoftumorinfiltratinglymphocytesinvestigatedusingroutineheslidesinsmallcelllungcancer
AT chenmingqiu clinicalsignificanceoftumorinfiltratinglymphocytesinvestigatedusingroutineheslidesinsmallcelllungcancer